Korean J Obstet Gynecol.  2001 May;44(5):845-851.

Spectral Analysis of Fetal Heart Rate Variability in Fetal Distress

Affiliations
  • 1Department of Obstetrics and Gynecology, Medical College, Catholic University, Seoul.
  • 2Department of Physics, Inje University, Kimhae, Korea.

Abstract


OBJECTIVE
To evaluate the usefulness of power spectral analysis on fetal heart rate variability as a new diagnostic method of fetal distress. STUDY DESIGN: Among 76 pregnant women who underwent computerized electronic fetal monitoring and cord blood gas analysis, we divided them into 3 groups, i.e.; normal fetus group (36), presumed distress group (26) and acidemic distress group (14). In order to perform linear analysis on the raw data of the fetal heart rate, after resampling, we performed Fourier transformation and investigated power distributions among very low frequency (VLF), low frequency (LF), high frequency (HF) bands, and autonomic balance (LF/HF).
RESULTS
The results of the spectral analysis showed that in normal fetus group, the difference in the distribution of power spectrums of VLF, LF and HF was significantly higher than in presumed distress group and acidemic distress group. In fetal distress, the LF and VLF value (0.0023, 0.0437) were good predictors (sensitivity 97.5%, 75.0% and specificity 86.1%, 94.4%). The LF value (0.0013) was a good predictor in fetal acidemia (sensitivity 97.5% and specificity 86.1%).
CONCLUSIONS
A computerized spectral analysis of fetal heart rate variation is a good predictor of fetal distress, which is made automatically and objectively.

Keyword

fetal distress; variability; power spectral analysis

MeSH Terms

Female
Fetal Blood
Fetal Distress*
Fetal Heart*
Fetal Monitoring
Fetus
Fourier Analysis
Heart Rate, Fetal*
Humans
Pregnancy
Pregnant Women
Sensitivity and Specificity
Full Text Links
  • KJOG
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr